New portable blood analyser can detect anaemia

Image
Press Trust of India Washington
Last Updated : Oct 04 2017 | 1:42 PM IST
Scientists have developed a small portable device that can detect hemoglobin levels in blood samples, and diagnose anaemia - a disease that affects about one quarter of the world's population.
Hemoglobin is a protein found in red blood cells that transports oxygen throughout the body. As the concentration of hemoglobin decreases, the body becomes starved of oxygen, often resulting in dizziness, fatigue, shortness of breath, and abnormal heart rate.
Blood analysers currently available measure hemoglobin by chemically rupturing the red blood cells in a sample. This technique requires hands-on expertise to prepare and run a sample, limiting the ability to monitor anaemia in many parts of the world.
"The most exciting aspect to this analyser is that it uses whole blood and does not require the additional steps and reagents to prepare a sample," said Nathan Sniadecki, associate professor at the University of Washington in the US.
The device only requires a few drops of blood for analysis, researchers said.
"You just run blood into the channel and that's it. It can be used anywhere," said Nikita Taparia, a doctoral candidate at Snaidecki's lab.
Anaemic blood transmits more light compared to normal blood, so the severity of anaemia can be measured as a ratio of transmitted to original light intensity.
To simulate anaemia, the researchers diluted blood samples with a buffer solution.
The blood analyser was effective at predicting cases of moderate to severe anaemia, defined as less than 10 grammes per decilitre of hemoglobin in a sample. The analyser did not produce any false negative results.
The primary cause of anaemia is iron deficiency, but it can co-occur with other conditions, such as malaria and genetic disorders like sickle cell.
Severe anaemia can lead to increased maternal and child mortality. It also impairs cognitive and physical development in children.
The current design is a prototype that could be integrated with other microfluidic devices to analyse whole blood samples in parallel to diagnose anaemia and other underlying factors that could contribute to the disease, researchers said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 04 2017 | 1:42 PM IST

Next Story